Totally agree. My main problem with BLA is that they are still blaming the messenger (Glaucus) not management. Shorters dont overvalue assets etc etc.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025